NGP 555 is primarily used in research settings for its potential neuroprotective properties. It has shown promise in preclinical studies targeting neurodegenerative conditions such as Parkinson’s disease. The compound appears to support neuronal survival by modulating specific signaling pathways involved in cell death and inflammation. Due to its ability to cross the blood-brain barrier, NGP 555 is being explored as a candidate for central nervous system therapeutics. It is not currently approved for clinical use but remains an active compound in drug development for neurological disorders.